These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 30317150)

  • 1. Fasciola hepatica, TGF-β and host mimicry: the enemy within.
    Musah-Eroje M; Flynn RJ
    Curr Opin Microbiol; 2018 Dec; 46():80-85. PubMed ID: 30317150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Trematode Parasite Derived Growth Factor Binds and Exerts Influences on Host Immune Functions via Host Cytokine Receptor Complexes.
    Sulaiman AA; Zolnierczyk K; Japa O; Owen JP; Maddison BC; Emes RD; Hodgkinson JE; Gough KC; Flynn RJ
    PLoS Pathog; 2016 Nov; 12(11):e1005991. PubMed ID: 27806135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β superfamily members from the helminth Fasciola hepatica show intrinsic effects on viability and development.
    Japa O; Hodgkinson JE; Emes RD; Flynn RJ
    Vet Res; 2015 Mar; 46():29. PubMed ID: 25879787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A host-independent role for Fasciola hepatica transforming growth factor-like molecule in parasite development.
    Musah-Eroje M; Hoyle RC; Japa O; Hodgkinson JE; Haig DM; Flynn RJ
    Int J Parasitol; 2021 May; 51(6):481-492. PubMed ID: 33581140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and expression of a transforming growth factor beta (TGF-β) homologue in the tropical liver fluke Fasciola gigantica.
    Japa O; Prakhammin K; Flynn RJ
    Parasitol Res; 2022 Dec; 121(12):3547-3559. PubMed ID: 36194274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Evaluation of the
    Ricafrente A; Nguyen H; Tran N; Donnelly S
    Front Immunol; 2020; 11():608686. PubMed ID: 33584684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycans from Fasciola hepatica Modulate the Host Immune Response and TLR-Induced Maturation of Dendritic Cells.
    Rodríguez E; Noya V; Cervi L; Chiribao ML; Brossard N; Chiale C; Carmona C; Giacomini C; Freire T
    PLoS Negl Trop Dis; 2015 Dec; 9(12):e0004234. PubMed ID: 26720149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic analysis of Fasciola hepatica excretory and secretory products (FhESPs) involved in interacting with host PBMCs and cytokines by shotgun LC-MS/MS.
    Liu Q; Huang SY; Yue DM; Wang JL; Wang Y; Li X; Zhu XQ
    Parasitol Res; 2017 Feb; 116(2):627-635. PubMed ID: 27866265
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Ryan S; Shiels J; Taggart CC; Dalton JP; Weldon S
    Front Immunol; 2020; 11():2182. PubMed ID: 32983184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory molecules of Fasciola hepatica: candidates for both vaccine and immunotherapeutic development.
    Dalton JP; Robinson MW; Mulcahy G; O'Neill SM; Donnelly S
    Vet Parasitol; 2013 Aug; 195(3-4):272-85. PubMed ID: 23623183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of a member of the Fasciola hepatica saposin-like protein family.
    Espino AM; Hillyer GV
    J Parasitol; 2003 Jun; 89(3):545-52. PubMed ID: 12880256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fasciola hepatica vaccine: we may not be there yet but we're on the right road.
    Molina-Hernández V; Mulcahy G; Pérez J; Martínez-Moreno Á; Donnelly S; O'Neill SM; Dalton JP; Cwiklinski K
    Vet Parasitol; 2015 Feb; 208(1-2):101-11. PubMed ID: 25657086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel ex vivo immunoproteomic approach characterising Fasciola hepatica tegumental antigens identified using immune antibody from resistant sheep.
    Cameron TC; Cooke I; Faou P; Toet H; Piedrafita D; Young N; Rathinasamy V; Beddoe T; Anderson G; Dempster R; Spithill TW
    Int J Parasitol; 2017 Aug; 47(9):555-567. PubMed ID: 28455238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evasion of Host Immunity During Fasciola hepatica Infection.
    Flynn RJ; Musah-Eroje M
    Methods Mol Biol; 2020; 2137():107-115. PubMed ID: 32399924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low allelic diversity in vaccine candidates genes from different locations sustain hope for Fasciola hepatica immunization.
    Dominguez MF; González-Miguel J; Carmona C; Dalton JP; Cwiklinski K; Tort J; Siles-Lucas M
    Vet Parasitol; 2018 Jul; 258():46-52. PubMed ID: 30105977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasciola hepatica-derived molecules as potential immunomodulators.
    Corral-Ruiz GM; Sánchez-Torres LE
    Acta Trop; 2020 Oct; 210():105548. PubMed ID: 32505597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune modulation by helminth parasites of ruminants: implications for vaccine development and host immune competence.
    McNeilly TN; Nisbet AJ
    Parasite; 2014; 21():51. PubMed ID: 25292481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasciola hepatica and Fasciola gigantica: comparison of cellular response to experimental infection in sheep.
    Zhang WY; Moreau E; Hope JC; Howard CJ; Huang WY; Chauvin A
    Exp Parasitol; 2005 Nov; 111(3):154-9. PubMed ID: 16126202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of a Peptide-Carrier Vaccine Based on the Highly Immunogenic Fasciola hepatica Leucine Aminopeptidase.
    Salazar C; Tort JF; Carmona C
    Methods Mol Biol; 2020; 2137():191-204. PubMed ID: 32399930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of functional genomic tools in trematodes: RNA interference and luciferase reporter gene activity in Fasciola hepatica.
    Rinaldi G; Morales ME; Cancela M; Castillo E; Brindley PJ; Tort JF
    PLoS Negl Trop Dis; 2008 Jul; 2(7):e260. PubMed ID: 18612418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.